Agree. Yuman is certainly being acknowledged in many ways at the moment. He seems to be involved across several parts that are now coming together like a jig saw puzzle. All parts seem to safe, effective and lower cost.. The way this is heading he must be on a short list for a Noble Prize if/when his ambition is eventually realised through IMU and its partners. He certainly deserves it.
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration, page-18
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
